MANE
Veradermics, IncorporatedNYSEHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.12B
P/E Ratio
—
EPS
$-2.11
Beta
—
52W High
$69.41
52W Low
$32.00
50-Day MA
$51.29
200-Day MA
$51.29
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Veradermics, Incorporated
Veradermics, Incorporated is a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -219.10% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-131.48 |
| Price-to-Book | 14.88 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $37.34M |
| Float | 408,740 |
| % Insiders | 3.39% |
| % Institutions | 50.09% |
Analyst Ratings
Consensus ($78.33 target)
4
BuyData last updated: 4/8/2026